Consistent with these observations, tumor weight was higher in the CLU-overexpression group than in the vector control group, while tumors from the BCL2L1-sh group were lighter than those from the CLU-OE group (Supplementary Figure S8C). The gene discussed is BCL2L1; the disease is neoplasm.